Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Glycerol and Acipimox

supplement:

Glycerol

Research Papers that Mention the Interaction

The rise in plasma free fatty acids and glycerol was almost totally prevented by Acipimox , and no significant rise in the utilization of lipids, evaluated by indirect calorimetry, was observed.
Journal of applied physiology  •  1993  |  View Paper
Acipimox treatment, produced significantly lower fat oxidation (36.9 +/- 12.8% vs 50.2 +/- 16.1%, P = 0.011), and lower plasma concentrations of FFA and glycerol (P = < 0.0001 and P = < 0.0001, respectively).
Postgraduate medical journal  •  1993  |  View Paper
After administration of acipimox , lipolysis was inhibited as reflected by lower plasma non-esterified fatty acid (0.05 +/- 0.02 versus 0.55 +/- 0.05 mmol/l, P less than 0.001) and blood glycerol (8 +/- 1 versus 56 +/- 8 mumol/l, P less than 0.001) concentrations.
Clinical science  •  1992  |  View Paper
These data indicate that met-GH induces lipolysis in man, increasing both FFA and glycerol levels, and that ACX blocks these effects.
Journal of endocrinological investigation  •  1992  |  View Paper
In submaximally stimulated adipose tissue (isoprenaline 10(-7) mol/l) acipimox (10(-4) mol/l) fully inhibited release of fatty acids (P less than 0.05) and glycerol (P less than 0.025) to basal rates.
In unstimulated adipose tissue acipimox (10(-3) mol/l) reduced the rate of glycerol release (P less than 0.05), but not the rate of fatty acid release.
The release of fatty acids and glycerol from adipose tissue maximally stimulated by isoprenaline (10(-5) mol/l) fell by 40 and 25% respectively (P less than 0.025 and P less than 0.025) in the presence of acipimox (10(-5) mol/l).
Clinical science  •  1985  |  View Paper
Glycogen synthesis from glycerol tended to decrease when lipolysis was suppressed by acipimox , although the statistical significance of this effect was marginal.
Nutrition and cancer  •  1997  |  View Paper